Q. Earlier this year, McKinsey shared research findings of how while organizations have seen usage with gen AI tools surge, from a value capture standpoint, “…these are still early days—few are experiencing meaningful bottom-line impacts.”[1] And this analysis builds …
Much of the conversation about healthcare innovation is dominated by breakthroughs in new pharmaceutical therapies. While many drug treatments are truly lifesaving, Karthik Kuppusamy, PhD, Senior Vice President of Clinical Solutions at Quest Diagnostics, argues that detecting disease in its …
The integration of AI in pharmaceutical research and development (R&D) holds immense potential to accelerate drug discovery, optimize clinical operations, and improve patient outcomes. However, a persistent challenge remains: the data gap. AI-driven models are only as strong as the …
